Pharmaron Beijing Co Ltd (SZSE:300759) Share Price

Company Profile

Business description
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry, and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services, Clinical development services, and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
Contact
6 Tai-He Road
8th Floor, Block 1
Beijing Economic Technological Development Area
Beijing100176
CHN
T: +86 1057330087
https://www.pharmaron.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
22,908

Recommended

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Matthew Dolgin, CFA | 20 October 2025

Shares plunged over 17% after reporting disappointing results.

Angus Hewitt, CFA | 20 October 2025

Growth outlook solid, but upside more than priced in.

Shaun Ler | 19 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,391.20	17.50	0.19%
CAC 40	8,206.07	31.87	0.39%
DAX 40	24,258.80	427.81	1.80%
Dow JONES (US)	46,706.58	515.97	1.12%
FTSE 100	9,403.57	49.00	0.52%
HKSE	26,347.37	488.54	1.89%
NASDAQ	22,990.54	310.57	1.37%
Nikkei 225	49,929.81	744.31	1.51%
NZX 50 Index	13,356.12	11.16	0.08%
S&P 500	6,735.13	71.12	1.07%
S&P/ASX 200	9,094.10	18.20	0.20%
SSE Composite Index	3,899.64	35.75	0.93%